Sounds about right OSD... and this may be our man:

Sounds about right OSD... and this may be our man:

https://www.linkedin.com/in/grahambell/

On another note, here's info from our Feb. 5th 'Letter to Shareholders' (LTS):

Quote:

---

KL
We are in the process of making our mold, which will allow us to reduce our costs by 50%. Each mold can make 150,000 to 200,000 units. I will be travelling back to KL to start production shortly.

---

Now today's LTS states the following:

Quote:

---

Our new mold will be able to create between 50,000 and 75,000 units at a significant discount to what we currently pay for product and all those savings go right to the bottom line.

---

All still good but makes me wonder whether something slightly changed regarding the new mold and its capability regarding how many units it produces... will make a difference to bottom line but whatever we have new is a plus so isn't that concerning.

My reaction to today's update as posted elsewhere:
Best line in the entire update (great numbers out in the filing yesterday)... once DE is taken care of, all revenue becomes ONCI's... grow the bottom line and the rest follows. Audit and name change will move ONCI onto next chapter. Now, here's a truly unique businessman/CEO in the gutter of OTC... which brings me to that next chapter: climbing up the tiers onto the higher exchange...



Best to all with ONCI/HEXA !